326 related articles for article (PubMed ID: 10612504)
21. Fixed combination of latanoprost and timolol vs individual components for primary open-angle glaucoma or ocular hypertension: a randomized, double-masked study.
Higginbotham EJ; Olander KW; Kim EE; Grunden JW; Kwok KK; Tressler CS;
Arch Ophthalmol; 2010 Feb; 128(2):165-72. PubMed ID: 20142538
[TBL] [Abstract][Full Text] [Related]
22. Efficacy of single glaucoma medication in combined latanoprost and timolol XE therapy in patients with open-angle glaucoma and ocular hypertension: a discontinuation study.
Kobayashi H
J Ocul Pharmacol Ther; 2012 Aug; 28(4):387-91. PubMed ID: 22335426
[TBL] [Abstract][Full Text] [Related]
23. Efficacy of latanoprost in reducing intraocular pressure in patients with primary angle-closure glaucoma.
Chew PT; Hung PT; Aung T
Surv Ophthalmol; 2002 Aug; 47 Suppl 1():S125-8. PubMed ID: 12204708
[TBL] [Abstract][Full Text] [Related]
24. The safety and efficacy of timolol 0.5% in xanthan gum versus timolol gel forming solution 0.5%.
Stewart WC; Sharpe ED; Stewart JA; Hott CE
Curr Eye Res; 2002 May; 24(5):387-91. PubMed ID: 12434307
[TBL] [Abstract][Full Text] [Related]
25. Timolol hemihydrate vs timolol maleate to treat ocular hypertension and open-angle glaucoma.
DuBiner HB; Hill R; Kaufman H; Keates EU; Zimmerman TJ; Mandell AI; Mundorf TK; Bahr RL; Schwartz LW; Towey AW; Hurvitz LM; Starita RJ; Sassani JW; Ropo A; Gunn R; Stewart WC
Am J Ophthalmol; 1996 May; 121(5):522-8. PubMed ID: 8610795
[TBL] [Abstract][Full Text] [Related]
26. Comparison of the additive intraocular pressure-lowering effect of latanoprost and dorzolamide when added to timolol in patients with open-angle glaucoma or ocular hypertension: a randomized, open-label, multicenter study in Greece.
Petounis A; Mylopoulos N; Kandarakis A; Andreanos D; Dimitrakoulias N
J Glaucoma; 2001 Aug; 10(4):316-24. PubMed ID: 11558817
[TBL] [Abstract][Full Text] [Related]
27. Efficacy and safety of latanoprost versus pilocarpine/timolol maleate fixed combination in patients with primary open-angle glaucoma or ocular hypertension.
Kałuzny J; Sobecki R; Czechowicz-Janicka K; Kecik D; Kałuzny BJ; Stewart JA; Stewart WC
Acta Ophthalmol; 2008 Dec; 86(8):860-5. PubMed ID: 18721251
[TBL] [Abstract][Full Text] [Related]
28. Comparison of ocular hypotensive effect and safety of brinzolamide and timolol added to latanoprost.
Miura K; Ito K; Okawa C; Sugimoto K; Matsunaga K; Uji Y
J Glaucoma; 2008; 17(3):233-7. PubMed ID: 18414111
[TBL] [Abstract][Full Text] [Related]
29. Latanoprost : an update of its use in glaucoma and ocular hypertension.
Perry CM; McGavin JK; Culy CR; Ibbotson T
Drugs Aging; 2003; 20(8):597-630. PubMed ID: 12795627
[TBL] [Abstract][Full Text] [Related]
30. Around-the-clock intraocular pressure reduction with once-daily application of latanoprost by itself or in combination with timolol.
Rácz P; Ruzsonyi MR; Nagy ZT; Gaygi Z; Bito LZ
Arch Ophthalmol; 1996 Mar; 114(3):268-73. PubMed ID: 8600885
[TBL] [Abstract][Full Text] [Related]
31. Twenty-four-hour control with latanoprost-timolol-fixed combination therapy vs latanoprost therapy.
Konstas AG; Boboridis K; Tzetzi D; Kallinderis K; Jenkins JN; Stewart WC
Arch Ophthalmol; 2005 Jul; 123(7):898-902. PubMed ID: 16009829
[TBL] [Abstract][Full Text] [Related]
32. The safety and efficacy of switching timolol maleate 0.5% solution to timolol hemihydrate 0.5% solution given twice daily.
Mundorf TK; Cate EA; Sine CS; Otero DW; Stewart JA; Stewart WC
J Ocul Pharmacol Ther; 1998 Apr; 14(2):129-35. PubMed ID: 9572538
[TBL] [Abstract][Full Text] [Related]
33. Comparison of the intraocular pressure-lowering effect of latanoprost and timolol in patients with chronic angle closure glaucoma: a preliminary study.
Aung T; Wong HT; Yip CC; Leong JY; Chan YH; Chew PT
Ophthalmology; 2000 Jun; 107(6):1178-83. PubMed ID: 10857840
[TBL] [Abstract][Full Text] [Related]
34. The Efficacy of a Latanoprost/Timolol Fixed Combination Versus Latanoprost and Timolol Gel-forming Solution Unfixed Combination on Daytime Intraocular Pressure.
Özyol E; Özyol P
J Glaucoma; 2016 Feb; 25(2):135-9. PubMed ID: 25264990
[TBL] [Abstract][Full Text] [Related]
35. Short-term effect of latanoprost and timolol eye drops on tear fluid and the ocular surface in patients with primary open-angle glaucoma and ocular hypertension.
Thygesen J; Aaen K; Theodorsen F; Kessing SV; Prause JU
Acta Ophthalmol Scand; 2000 Feb; 78(1):37-44. PubMed ID: 10726786
[TBL] [Abstract][Full Text] [Related]
36. Patient preference, efficacy, and compliance with timolol maleate ophthalmic gel-forming solution versus timolol maleate ophthalmic solution in patients with ocular hypertension or open-angle glaucoma.
Schenker H; Maloney S; Liss C; Gormley G; Hartenbaum D
Clin Ther; 1999 Jan; 21(1):138-47. PubMed ID: 10090431
[TBL] [Abstract][Full Text] [Related]
37. A 6-week, double-masked, parallel-group study of the efficacy and safety of travoprost 0.004% compared with latanoprost 0:005%/timolol 0.5% in patients with primary open-angle glaucoma or ocular hypertension.
Franks WA; Renard JP; Cunliffe IA; Rojanapongpun P
Clin Ther; 2006 Mar; 28(3):332-9. PubMed ID: 16750448
[TBL] [Abstract][Full Text] [Related]
38. Circadian intraocular pressure control with dorzolamide versus timolol maleate add-on treatments in primary open-angle glaucoma patients using latanoprost.
Tamer C; Oksüz H
Ophthalmic Res; 2007; 39(1):24-31. PubMed ID: 17164574
[TBL] [Abstract][Full Text] [Related]
39. Comparison of the efficacy and safety of latanoprost 0.005% compared to brimonidine 0.2% or dorzolamide 2% when added to a topical beta-adrenergic blocker in patients with primary open-angle glaucoma or ocular hypertension.
Stewart WC; Sharpe ED; Day DG; Kolker AE; Konstas AG; Lee WH; Rieser JC; Chopra H; Holmes KT
J Ocul Pharmacol Ther; 2000 Jun; 16(3):251-9. PubMed ID: 10872922
[TBL] [Abstract][Full Text] [Related]
40. Twenty-four-hour diurnal curve comparison of commercially available latanoprost 0.005% versus the timolol and dorzolamide fixed combination.
Konstas AG; Papapanos P; Tersis I; Houliara D; Stewart WC
Ophthalmology; 2003 Jul; 110(7):1357-60. PubMed ID: 12867391
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
